Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease
Tài liệu tham khảo
Chitturi, 2001, Etiopathogenesis of nonalcoholic steatohepatitis, Semin. Liver Dis., 21, 27, 10.1055/s-2001-12927
Angulo, 2002, Nonalcoholic fatty liver disease, N. Engl. J. Med., 346, 1221, 10.1056/NEJMra011775
Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8
Kuwajima, 1991, Animal model of systemic carnitine deficiency: analysis in C3H-2 strain of mouse associated with juvenile visceral steatosis, Biochem. Biophys. Res. Commun., 174, 1090, 10.1016/0006-291X(91)91532-H
Bjorkegren, 2002, Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury, J. Biol. Chem., 277, 5476, 10.1074/jbc.M108514200
Sessler, 1998, Polyunsaturated fatty acid regulation of gene expression, J. Nutr., 128, 923, 10.1093/jn/128.6.923
Nakamura, 2000, Regulation of hepatic delta-6 desaturase expression and its role in the polyunsaturated fatty acid inhibition of fatty acid synthase gene expression in mice, J. Nutr., 130, 1561, 10.1093/jn/130.6.1561
Clarke, 2001, Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome, J. Nutr., 131, 1129, 10.1093/jn/131.4.1129
Reddy, 2001, Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal β-oxidation, PPARα, and steatohepatitis, Am. J. Physiol., 281, G1333
Mahfouz, 1984, Effect of dietary fats on desaturase activities and the biosynthesis of fatty acids in rat-liver microsomes, Lipids, 19, 214, 10.1007/BF02534800
Sies, 1986, Biochemistry of oxidative stress, Angew. Chem. Int. Ed. Engl., 25, 1058, 10.1002/anie.198610581
Sevanian, 1985, Mechanisms and consequences of lipid peroxidation in biological systems, Ann. Rev. Nutr., 5, 365, 10.1146/annurev.nu.05.070185.002053
Araya, 2004, Increase in long-chain polyunsaturated fatty acids n-6/n-3 ratio in relation to hepatic steatosis in nonalcoholic fatty liver disease patients, Clin. Sci., 106, 635, 10.1042/CS20030326
Yoshikawa, 2002, Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements, J. Biol. Chem., 277, 1705, 10.1074/jbc.M105711200
Matsuzaka, 2002, Dual regulation of mouse delta(5)- and delta(6)-desaturase gene expression by SREBP-1 and PPARalpha, J. Lipid Res., 43, 107, 10.1016/S0022-2275(20)30193-0
Osborne, 2000, Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action, J. Biol. Chem., 275, 32379, 10.1074/jbc.R000017200
Clarke, 1999, Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors, Am. J. Clin. Nutr., 70, 566, 10.1093/ajcn/70.4.566
Kersten, 2002, Effects of fatty acids on gene expression: role of peroxisome proliferator-activated receptor alpha, liver X receptor alpha, and sterol regulatory-element binding protein-1c, Proc. Nutr. Soc., 61, 371, 10.1079/PNS2002169
Lindén, 2002, Influence of peroxisome proliferator-activated receptor α agonists on the intracellular turnover and secretion of apolipoprotein (Apo)B-100 and ApoB-48, J. Biol. Chem., 277, 23044, 10.1074/jbc.M110416200
Charlton, 2002, Apolipoprotein synthesis in nonalcoholic steatohepatitis, Hepatology, 35, 898, 10.1053/jhep.2002.32527
Meunier-Durmort, 1996, Upregulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids, Biochem. J., 319, 483, 10.1042/bj3190483
Carlsson, 2001, Effects of fatty acids and growth hormone on liver fatty acid-binding protein and PPARα in rat liver, Am. J. Physiol., 281, E772
Kersten, 1999, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J. Clin. Invest., 103, 1489, 10.1172/JCI6223
Baylin, 2002, Adipose tissue biomarkers of fatty acid intake, Am. J. Clin. Nutr., 76, 750, 10.1093/ajcn/76.4.750
Larqué, 2000, Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats, Pediatr. Res., 47, 278, 10.1203/00006450-200002000-00021
Burke, 1999, Conditionally essential fatty acid deficiencies in end-stage liver disease, Nutrition, 15, 302, 10.1016/S0899-9007(99)00002-7
Okita, 2002, Habitual food intake and polyunsaturated fatty acid deficiency in liver cirrhosis, Nutrition, 18, 304, 10.1016/S0899-9007(01)00756-0
Videla, 1995, Biochemical mechanisms in hepatotoxicity: oxidative stress induced by xenobiotics and hormonal changes, J. Braz. Assoc. Adv. Sci., 47, 385
Jaeschke, 2002, Mechanisms of hepatotoxicity, Toxicol. Sci., 65, 166, 10.1093/toxsci/65.2.166
Tsukamoto, 2002, Redox regulation of cytokine expression in Kupffer cells, Antioxid. Redox Signaling, 4, 741, 10.1089/152308602760598882
Martindale, 2002, Cellular responses to oxidative stress: signaling for suicide and survival, J. Cell. Physiol., 192, 1, 10.1002/jcp.10119
Klatt, 2000, Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress, Eur. J. Biochem., 267, 4928, 10.1046/j.1432-1327.2000.01601.x
Videla, 2004, Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients, Clin. Sci., 106, 261, 10.1042/CS20030285
Cortez-Pinto, 1999, A peroxidação dos lípidos na esteatohepatite não alcoólica: relação com a esteatose, J. Português Gastroenterol., 6, 234
Loguercio, 2001, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects, J. Hepatol., 35, 568, 10.1016/S0168-8278(01)00192-1
Sanyal, 2001, Nonalcoholic steatohepatitis: association with insulin resistance and mitochondrial abnormalities, Gastroenterology, 120, 1183, 10.1053/gast.2001.23256
García-Monzón, 2000, Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity, J. Hepatol., 33, 716, 10.1016/S0168-8278(00)80301-3
Seki, 2002, In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases, J. Hepatol., 37, 56, 10.1016/S0168-8278(02)00073-9
Stadtman, 1990, Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences, Free Radic. Biol. Med., 9, 315, 10.1016/0891-5849(90)90006-5
Chalasani, 2003, Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis, Hepatology, 37, 544, 10.1053/jhep.2003.50095
Weltman, 1998, Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis, Hepatology, 27, 128, 10.1002/hep.510270121
Lucas, 1998, Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation, Fundam. Clin. Pharmacol., 12, 553, 10.1111/j.1472-8206.1998.tb00985.x
de la Maza, 2000, Changes in microsomal activity in alcoholism and obesity, Alcohol. Clin. Exp. Res., 24, 605, 10.1111/j.1530-0277.2000.tb02031.x
Lieber, 1997, Cytochrome P-4502E1: its physiological and pathological role, Physiol. Rev., 77, 517, 10.1152/physrev.1997.77.2.517
Zangar, 1997, Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes, Arch. Biochem. Biophys., 337, 217, 10.1006/abbi.1996.9785
Song, 1989, Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization, J. Biol. Chem., 264, 3568, 10.1016/S0021-9258(18)94103-7
Robertson, 2001, Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress, Am. J. Physiol. Gastrointest. Liver Physiol., 281, G1135, 10.1152/ajpgi.2001.281.5.G1135
Koteish, 2001, Animal models of steatosis, Semin. Liver Dis., 21, 89, 10.1055/s-2001-12932
Kaplan, 1998, Leptin, obesity, and liver disease, Gastroenterology, 115, 997, 10.1016/S0016-5085(98)70272-0
Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD single topic conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193
Crespo, 2001, Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, Hepatology, 34, 1158, 10.1053/jhep.2001.29628
Wigg, 2001, The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxemia, and tumor necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis, Gut, 48, 206, 10.1136/gut.48.2.206
Kugelmas, 2003, Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E, Hepatology, 38, 413, 10.1053/jhep.2003.50316
Schulze-Osthoff, 1992, Cytotoxic activity of tumor necrosis factor is mediated by early damage to mitochondrial functions, J. Biol. Chem., 267, 5317, 10.1016/S0021-9258(18)42768-8
Caldwell, 1999, Mitochondrial abnormalities in non-alcoholic steatohepatitis, J. Hepatol., 31, 430, 10.1016/S0168-8278(99)80033-6
Cortéz-Pinto, 1999, Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study, JAMA, 282, 1659, 10.1001/jama.282.17.1659
Delerive, 2001, Peroxisome proliferator-activated receptors in inflammation control, J. Endocrinol., 169, 453, 10.1677/joe.0.1690453
Lavine, 2000, Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study, J. Pediatr., 136, 734, 10.1067/mpd.2000.106566
Hasegawa, 2001, Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study, Aliment. Pharmacol. Ther., 15, 1667, 10.1046/j.1365-2036.2001.01083.x
Sekiya, 2003, Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression, Hepatology, 38, 1529, 10.1016/j.hep.2003.09.028
Ip, 2003, Central role of PPAR-α-dependent hepatic lipid turnover in dietary steatohepatitis in mice, Hepatology, 38, 123, 10.1053/jhep.2003.50307
Uesugi, 2001, Delivery of IκB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats, Hepatology, 34, 1149, 10.1053/jhep.2001.29400
Aleynik, 1999, Dilinoleoylphosphatidylcholine is the active antioxidant of polyenylphosphatidylcholine, J. Invest. Med., 47, 507
Aleynik, 2003, Polyenylphosphatidylcholine corrects the alcohol-induced hepatic oxidative stress by restoring S-adenosylmethionine, Alcohol Alcohol., 38, 208, 10.1093/alcalc/agg066